Levodopa or a dopamine agonist?

Citations

1. DeLong MR, Juncos JL (2005). Parkinson's disease and other movement disorders. In DL Kasper et al., eds., Harrison's Principles of Internal Medicine, 16th ed., pp. 2406–2418. New York: McGraw-Hill.

2. Rascol O, et al. (2000). A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. New England Journal of Medicine, 342(20): 1484–1491.

Author:	Monica Rhodes	Last Updated: December 13, 2006
Medical Review:	E. Gregory Thompson, MD - Internal Medicine Colin Chalk, MD, CM, FRCPC - Neurology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.